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Abstract
Background: West Nile virus (WNV) can persist long term in the brain and kidney tissues of humans, non-human primates,
and hamsters. In this study, mice were infected with WNV strain H8912, previously cultured from the urine of a persistently
infected hamster, to determine its pathogenesis in a murine host.
Methodology/Principal Findings: We found that WNV H8912 was highly attenuated for neuroinvasiveness in mice.
Following a systemic infection, viral RNA could be detected quickly in blood and spleen and much later in kidneys. WNV
H8912 induced constitutive IL-10 production, upregulation of IFN-b and IL-1b expression, and a specific IgM response on
day 10 post-infection. WNV H8912 persisted preferentially in kidneys with mild renal inflammation, and less frequently in
spleen for up to 2.5 months post infection. This was concurrent with detectable serum WNV-specific IgM and IgG
production. There were also significantly fewer WNV- specific T cells and lower inflammatory responses in kidneys than in
spleen. Previous studies have shown that systemic wild-type WNV NY99 infection induced virus persistence preferentially in
spleen than in mouse kidneys. Here, we noted that splenocytes of WNV H8912-infected mice produced significantly less IL-
10 than those of WNV NY99-infected mice. Finally, WNV H8912 was also attenuated in neurovirulence. Following intracranial
inoculation, WNV persisted in the brain at a low frequency, concurrent with neither inflammatory responses nor neuronal
damage in the brain.
Conclusions: WNV H8912 is highly attenuated in both neuroinvasiveness and neurovirulence in mice. It induces a low and
delayed anti-viral response in mice and preferentially persists in the kidneys.
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Introduction
West Nile virus (WNV) is a mosquito-borne flavivirus with a
positive-sense, single-stranded RNA genome that encodes three
structural proteins: the nucleocapsid protein (C), membrane and
envelope (E), and seven nonstructural (NS) proteins [1–2]. Human
infection results from mosquito bites, blood transfusion, organ
transplantation, breast feeding and in utero or occupational
exposure [3–6]. About 80% of human infections with WNV are
asymptomatic. Among persons with clinical illness, the features of
acute illness range from WN fever, to neuroinvasive conditions,
including meningitis, encephalitis, acute flaccid paralysis and
death [7–8]. There is no specific therapeutic agent for treatment of
WNV infection, and an approved vaccine for its prevention in
humans is not currently available. About 20–50% of WNV
convalescent patients have significant long-term morbidity years
after their acute illness; symptoms include muscle weakness and
pain, fatigue, memory loss, and ataxia [9–13]. Although the cause
of the persistent sequelae remains undefined, accumulating
evidence suggests that persistence of the virus and chronic
infection may play a role. Some WNV convalescent patients have
been reported to have detectable serum or cerebrospinal fluid
(CSF) WNV-specific IgM and - IgA years after the acute infection,
which is suggestive of the existence of viral antigens in the
periphery or the central nervous system (CNS) of these individuals
[14–16]. Indeed, WNV antigen or RNA has been detected in the
brain or urine of WNV patients ranging from a few months to
several years after the initial acute illness [17–18].
Persistent WNV infection has also been reported in non-human
primates, hamsters and mice [19–22]. The first well-documented
WNV persistence was reported by Pogodina [20] in non-human
primates in 1983, in which infectious virus was mostly detected in
the CNS tissues and kidneys for up to 5 K months. Experimental
infection of hamsters with the WNV NY99 strain induced chronic
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renal infection and persistent viruria for up to 8 months post-
infection, accompanied by moderate renal histopathologic changes
[22–23]. Siddharthan et al. [21] also demonstrated an active CNS
infection and chronic neuropathological lesions in hamsters for up
to 100 days after WNV infection. In comparison, infectious virus
was cleared from hamster blood and spleen within the first 2 weeks
of inoculation [23–24]. Following systemic infection of mice with
the wild-type WNV, virus persisted preferentially in skin, spinal
cord, brain and lymphoid tissues, but the persistence was found
less frequently in kidneys [19]. In a recent report, we have
demonstrated that infection by a strain of WNV H8912, cultured
from urine of a persistently infected hamster, induced a differential
proinflammatory cytokine response in mouse macrophage and
kidney epithelial cell lines [25]. In the present study, we attempted
to further define a murine model of persistent WNV renal
infection, using the hamster-derived WNV urine isolate H8912.
Methods
6- to 10-week-old C57BL/6 (B6) mice were purchased from
Jackson Laboratory (Bar Harbor, ME). Groups were age- and sex-
matched for each experiment and housed under identical
conditions. This study was performed in strict accordance with
the recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. All
animal experiments were carried out under a protocol approved
by the Institutional Animal Care and Use Committee at the
University of Texas Medical Branch.
Infection in mice
Two WNV strains were used: the parental wild-type strain
WNV NY385-99 (WNV NY99, [26]), which had been passaged
once in African green monkey kidney (Vero) cells and twice in
Aedes albopictus (C6/36) cells, and WNV H8912, which was
recovered from hamster urine 274 days post-infection after three
consecutive passages of a urine isolate from a persistently infected
hamster [27]. To evaluate its neuroinvasiveness, mice were
inoculated intraperitoneally (i.p.) with 10-fold serial dilutions of
WNV H8912, ranging from 102 to 106 PFU. For intracranial (i.c.)
infection, anesthetized mice were inoculated with 102, 104, and
106 PFU of WNV H8912 in 50 ml of PBS with 5% gelatin.
Infected mice were monitored twice daily for morbidity, including
lethargy, anorexia and ataxia.
Quantitative PCR (Q-PCR) for viral load, cytokine
production and leukocyte levels in the CNS
Spleen, kidney and brain tissues were harvested from the WNV-
infected mice or controls following perfusion with PBS. For the
WNV persistence study, tissues were homogenized and re-
suspended in modified Eagle’s medium (MEM, Invitrogen,
Carlsbad, CA) supplemented with 10% fetal bovine serum (FBS,
Sigma, St. Louis, MO). Tissue homogenate was then inoculated
into flask cultures of Vero cells three consecutive times (original
passage, followed by two blind serial passages harvested at weekly
intervals). At the final passage, infected cells were harvested and
assayed for WNV RNA by Q-PCR analysis. Non-infected Vero
cell samples were used as negative controls. Cells or tissues were
resuspended in Trizol (Invitrogen) for RNA extraction. 200 ng
RNA was used to synthesize cDNA by reverse transcription
(qScript, Quanta Biosciences). The sequences of the primer sets for
WNV envelope (WNVE), cytokine genes, and genes for leukocytes,
such as CD4+ and CD8+ T cells, neutrophils and monocytes, and
PCR reaction conditions were described previously [28–31]. The
assays were performed in an iCycler (Bio-Rad, Hercules, CA). To
normalize the samples, the same amount of cDNA was used in a
Q-PCR for b-actin. The ratio of the amount of amplified gene
compared with the amount of b-actin cDNA represented the
relative levels in each sample. For Il-10, Tgfb and leukocyte genes,
results were calculated based on Ct values by using the formula
2‘ -[Ct(cytokine or leukocyte gene)-Ct(b-actin)] as described in the user
manual (SA Biosciences). In the persistence study, samples were
considered positive for WNV RNA if the WNVE gene expression
level was significantly higher than the negative controls.
Bioplex
Culture supernatant or sera of infected mice were collected for
analysis of cytokine production by using a Bio-Plex Pro Mouse
Cytokine Assay (Biorad).
ELISA
Microtiter plates were coated with recombinant WNV-E
protein expressed in Drosophila melanogaster S2 cells [32] overnight
at 4uC at 100 ng/well in coating buffer [0.015 M Na2CO3, 0.03
M NaHCO3, and 0.003 M NaN3 (pH 9.6)]. Sera from infected
mice were diluted 1/40 in PBS with 2% BSA, added to the
duplicate wells, and incubated for 1 h at room temperature. Plates
were washed with PBS-Tween (PBS-T). Alkaline phosphatase-
conjugated goat anti-mouse IgG or IgM (Sigma) at a dilution of 1/
1000 in PBS-T was added for 1 h at room temperature. After
washing with PBS-T, color was developed with p-nitrophenyl
phosphate (Sigma) for 10 min and intensity determined at an
absorbance of 405 nm by using a spectrophotometer.
Kidney leukocyte isolation
Isolation of leukocytes from kidneys was performed by methods
described earlier [33–34]. Briefly, mice were perfused with PBS,
then the kidneys were removed and tissues were mashed through a
70-mm-pore-size strainer in RPMI with 5% FBS. The resulting cell
suspensions were centrifuged, and the pellet was resuspended in a
36% Percoll solution (Sigma) and gently overlaid onto 72% Percoll
in RPMI, and centrifuged at 10006 g for 30 min at room
Author Summary
West Nile virus (WNV) has been reported to persist long
term in the brain and kidney tissues of humans, non-
human primates, and hamsters. To define a murine model
of persistent WNV renal infection, we characterized
infection by WNV H8912, an isolate cultured previously
from the urine of a persistently infected hamster. Our
findings indicate that WNV strain H8912 is highly attenu-
ated in both neuroinvasiveness and neurovirulence for
mice. The virus persisted preferentially in kidneys of the
mouse, and less frequently in the spleen and the brain.
Moreover, mice infected with WNV H8912 had a delayed
induction of IFN- b and IL-1b expression and WNV- specific
IgM response, but a constitutive production of serum IL-
10. There was a lower proinflammatory response in mouse
kidneys when compared to equivalent findings in the
spleen. This response may lead to a reduced T cell
response in kidneys, which could ultimately contribute to
renal-specific WNV persistence. Defining a murine model
of WNV persistence by using a well-characterized, hamster-
derived WNV urine isolate should provide important
insights into understanding the mechanisms of WNV
persistence.
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Ethics     Statement
temperature with no brakes. Cells were harvested from the Percoll
interface and washed extensively in RPMI with 5% FBS.
Flow cytometry
Freshly isolated splenocytes and kidney leukocytes were
stained with PE-conjugated Pro5 MHC pentamers (H-2Db
SSVWNATTA and H-2Kb RSYCYLAT, Proimmune, Oxford,
UK) for 10 min at 22uC. WNV- infected BM-DCs were harvested
at 48 h post-infection and were stained with antibodies for cell
surface markers, including CD80, CD86, MHC II (e-Biosciences).
After staining, cells were washed and fixed with 0.5% parafor-
maldehyde in PBS and acquired by using a C6 Flow Cytometer
(Accuri cytometers, Ann Arbor, MI). To measure intracellular
cytokine production, splenocytes from WNV-infected mice or
controls were isolated and stimulated with WNV-specific NS3 and
E peptides (RRWCFDGPRTNTILE and PVGRLVTVNPFVSVA,
respectively [35]) for CD4 T cells, or WNV-specific NS4B and E
peptides (SSVWNATTA and IALTFLAV, respectively [36–37]) for
CD8 T cells for 5 h at 37uC. Golgi-plug (BD Biosciences) was added
at the beginning of stimulation. Cells were harvested, stained with
antibodies for CD4 or CD8, fixed in 2% paraformaldehyde, and
permeabilized with 0.5% saponin before adding PE-conjugated anti-
IFN-c, or control PE-conjugated rat IgG1 (eBiosciences, San Diego,
CA).
Histologic examination of tissues
Anesthetized mice were perfused with 30 ml of ice cold PBS.
Brains and kidneys were removed and fixed in 4% paraformal-
dehyde. Subsequently, specimens were transferred to 70% ethanol
and processed for histopathologic examination. Five-micron
paraffin sections were prepared for staining with hematoxylin &
eosin, in the case of kidneys, six sections were made for each
mouse. Stained sections were examined for lesions by a
pathologist, who was blinded to the origin of the samples. As a
lesion was defined, its incidence was scored based on presence or
absence in a single section, thus allowing for determination of %
incidence in the histologic material.
Cell culture and virus infection
Bone-marrow (BM)- derived dendritic cells (DCs) were gener-
ated as described previously [38]. Briefly, BM cells from B6 mice
were isolated and cultured for 6 days in RPMI-1640 supplemented
with granulocyte-macrophage-colony stimulating factor, and
interleukin-4 (Peprotech) to generate myeloid DC. Day 6-cultured
DCs were infected with WNV NY99 or WNV H8912 strain at a
multiplicity of infection (MOI) of 0.2. Primary cortical cultures
from mouse embryos of either sex were prepared as described
previously [39]. Briefly, cortices were dissected from B6 mouse
embryos (E18) and washed in Hanks’ balanced salt solution
(HBSS, Invitrogen). Meninges and excess white matter were
removed. Cortices were chopped into small tissue blocks (0.5–
1 mm3) and transferred to a sterile tube containing HBSS.
Cortical tissues were treated with 0.25% trypsin (Sigma) for 8 min
at 37uC, and dissociated to single cell suspensions, followed by
centrifugation at 1206 g for 5 min. The cell pellets were re-
suspended in Dulbecco’s Modified Eagle Media (DMEM,
Invitrogen) containing 10% FBS and 1% penicillin-streptomycin.
Cells were inoculated into culture plates coated with 20 mg/ml
poly-D-lysine (PDL, Sigma) in 0.1 M borate buffer (PH 8.5,
50 mM H3BO3, 12.5 mM Na2B4O7(10H2O)). Two hours later,
DMEM was replaced with Neurobasal Medium (Invitrogen)
supplemented with 2% B27 (Invitrogen), 1% penicillin-streptomy-
cin, and 0.5 mM L-glutamine. Cells were cultured at 37uC and
one-third of the medium was replenished every 3 days until 10
days in vitro. For WNV infection, 0.36106 cells were grown on the
coverslips in a 24-well tissue culture plate and infected with WNV
NY99 or WNV H8912 at a MOI of 0.003. At indicated time
points post-infection, supernatants were collected and measured
for viral titer by plaque assay. Cells were also harvested and
resuspended in Trizol (Invitrogen) for RNA extraction. Viral load
was determined by Q-PCR assay.
Plaque assay
Vero cells were seeded in 6-well plates in DMEM (Invitrogen)
supplemented with 10% FBS 24 h before infection. Serial dilutions
of cell culture supernatants of both NY99 and H8912 infected cells
were added and incubated for 1 h. Subsequently, DMEM
containing 2% FBS and 1% low-melting-point agarose were
added and the plates were incubated for 3 days. A second overlay
of 4 ml 1% agarose-medium containing 0.01% neutral red (Sigma)
was added to visualize plaques. Virus concentrations were
determined as PFU/ml.
Statistical analysis
Data analysis was performed by using Prism software (Graph-
Pad) statistical analysis. Values for viral burden, plaque assay, and
cytokine production experiments were presented as means 6
SEM. P values of these experiments were calculated with a non-
paired Student’s t test. Statistical significance was accepted at
P,0.05.
Results
WNV H8912 isolate was highly attenuated in
neuroinvasiveness in mice
WNV H8912 was originally isolated from urine of a WNV
persistently infected hamster. It has been shown to be highly
attenuated in neuroinvasiveness and to induce chronic renal
infection in hamsters [27]. To characterize WNV H8912 infection
in a murine model, we infected B6 mice i.p. with 10-fold serial
dilutions of 102 to 106 PFU of WNV H8912. Infected mice were
monitored twice daily for morbidity for over a month. All mice
survived infection (Fig. 1A); and less than 20% of the mice
infected with the highest dose (106 PFU) of WNV H8912
developed mild disease symptoms (ruffeled fur, irritability, etc).
We also measured viral load in blood, spleen and kidneys in B6
mice following an i.p. inoculation of 500 PFU of WNV H8912. At
days 1, 3, 6 and 10 post-infection, tissues were collected, and viral
load was measured by a Q-PCR assay. As shown in Fig. 1B,
viremia increased quickly by day 1 and declined on day 6 post-
infection compared to equivalent findings in naı̈ve mice (P,0.05).
Viral load in the spleen was also increased on day 1 and continued
to be detectable on day 10 post-infection (Fig. 1C, P,0.05 or
P,0.01). In contrast, viral load in kidneys was not detectable until
on day 10 post-infection (Fig. 1D, P,0.05). These results indicate
that WNV H8912 has a highly reduced neuroinvasiveness in mice,
and that its replication in blood, spleen and kidneys showed
differential kinetics.
Innate cytokine and antibody production in WNV H8912-
infected mice
Innate cytokine responses, including type 1 interferon (IFN)s,
proinflammatory cytokines and regulatory cytokines, play an
important role in protection and pathogenesis during wild-type
WNV NY99 infection [29,40–42]. To examine cytokine produc-
tion, we infected mice i.p. with 500 PFU of WNV H8912. Blood
was collected at days 1, 3, 6 and 10 post-infection for cytokine
Persistent West Nile Virus Infection in Mice
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measurement by Q-PCR and Bioplex. Compared to the samples
from non-infected mice, IFN-a gene expression was not changed
at any of the time points examined (Fig. 2A, P.0.05). There was
a 3–4 fold induction in IFN-b gene expression on day 10 post
infection (Fig. 2B, P,0.01). Higher interleukin (IL)-1b production
was also detected in serum on day 10 post infection (Fig. 2C,
P,0.01). No changes were noted in the expression of the two
genes at earlier time points nor in the production of other
proinflammatory cytokines, including IL-6 and tumor necrosis
factor (TNF)-a (Figs. 2B–2E, P.0.05). We found that WNV
H8912 constitutively induced serum IL-10 levels compared to
those in naı̈ve mice (Fig. 2F, P,0.01 or P,0.05). B cell-mediated
humoral immune responses are critical for host defense against
disseminated infection by WNV [43–45]. In particular, induction
of a specific, neutralizing IgM response early in the infection limits
viremia and dissemination into the CNS and protects the host
against lethal wild-type WNV infection [46]. Interestingly, WNV
H8912-infected mice had no detectable serum WNV-specific IgM
until at day 10 post-infection (Fig. 2G, P,0.01). In comparison,
there was a low WNV-specific IgG production at days 1 to 6 post-
infection and the titer was further increased at day 10 (Fig. 2H,
P,0.01). Together, these results suggest to us that WNV H8912-
infected mice had a delayed induction of IFN-b and IL-1b
expression and IgM response, but a constitutive production of
serum IL-10.
WNV H8912 persisted preferentially in mouse kidneys
following a systemic infection
In a previous report, the hamster-passaged WNV urine isolates,
including WNV H8912 were shown to induce persistent renal
infection in hamsters following a systemic infection [27]. Here, we
wondered whether WNV H8912 would induce persistent infection
in mice. At days 30, 60 and 84 post-infection, spleens and kidneys
were harvested from infected mice, and the tissue homogenate was
inoculated into Vero cells consecutively for three times before
detection of WNV RNA by Q- PCR assay. WNV RNA was
equally detected in both tissues at day 30 but at a higher frequency
in kidneys than in spleen tissues at days 60 and 84 post-infection
(Table 1). Furthermore, in mice at day 84 post-infection,
pathologic examination revealed a sporadic, focal chronic
inflammation consisting of clusters of lymphocytes in the
intertubular interstitium of all four kidney samples of experimental
mice that were detected as positive for WNV RNA (Fig. 3A,
right panel). The incidence of the inflammatory lesion varied
from 17% to 83% (number of sections with lesion present per 6
total sections/mouse) with a mean observance of 46%614%. No
such inflammatory lesions were observed in equivalent numbers of
kidney sections of control mice (Fig. 3A, left panel). Interest-
ingly, we noted that there was a detectable serum WNV-specific
IgM response at all these time points, though it dropped at days 30
and 84 post-infection compared to that of day 10 (Fig. 3B,
Figure 1. WNV H8912 infection in mice. A. Mice were injected with a 10-fold serial dilution of WNV H8912 and monitored twice daily (n = 3 per
group). B–D. Viral load in blood (B), spleen (C) and kidneys (D) was determined by using Q-PCR at the indicated time points post-infection. Data are
presented as means 6 SEM, n = 3–6. * P,0.05 or **P,0.01 compared to non-infected (NF) mice.
doi:10.1371/journal.pntd.0002275.g001
Persistent West Nile Virus Infection in Mice
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P,0.01). In comparison, WNV-specific IgG production was
increased at days 30 and 60 post infection compared to that at
day 10 (Fig. 3C, P,0.01). Both WNV-E- and NS4B-specific
CD8+ T cells dominated during wild-type WNV NY99 strain
infection [36–37]. In WNV H8912-infected mice, we found that
the number of these two T cell populations in the splenic tissues
were either maintained or increased at day 34 post-infection
compared to those on day 8 post-infection (Figs. 3D & 3E),
whereas the number of both T cell populations was significantly
lower in kidney tissues and was even reduced at the late stage of
infection (day 34) compared to those at day 8 (Figs. 3D & 3E). To
understand the underlying mechanism of WNV persistence, we
measured and compared the expression of innate cytokines in both
tissues. Our results showed that IL-6 expression levels in the spleen
were induced during the early stage of infection (days 1 to 10 post-
infection), but were reduced at days 30 and 60. In comparison, no
induction of IL-6 expression was observed in the kidneys of WNV
H8912-infected mice (Fig. S1A). The TNF-a expression level was
slightly increased in spleens throughout the course of infection,
whereas it was decreased in kidneys of H8912-infected mice except
at day 6 post-infection (Fig. S1B). Further, we did not note any
significant differences in the expression of regulatory cytokines,
such as TGF-b and IL-10, in these two tissues during WNV
H8912 infection (Figs. S1C & S1D). These results suggest that
WNV H8912 induces a persistent infection preferentially in mouse
kidneys rather than in the spleen, possibly due to the differential
proinflammatory cytokine expression and T cell responses in these
two tissues.
A previous report shows that systemic wild-type WNV NY99
infection induced virus persistence preferentially in the spleen than
in mouse kidneys [19]. We next compared splenic CD4+ and
CD8+ T cell responses following WNV H8912 or NY99 infection.
We noted CD4+ and CD8+ T cells of WNV H8912 or NY99-
infected mice produced similar levels of IFN-c upon ex vivo
stimulation with WNV peptides on days 8 and 38 post-infection
(Fig. 4A). Nevertheless, splenocytes of WNV H8912-infected mice
induced significantly less IL-10 production compared to those of
WNV NY99-infected mice upon ex vivo stimulation with PMA and
ionomycin (Fig. 4B, P,0.01). DCs represent the most important
antigen- presenting cells exhibiting the unique capacity to initiate
primary T cell responses and are permissive to WNV infection. At
day 2 post-infection, we noted 18–19% increase on the percentage
of CD80 and CD86 expression on WNV H8912-infected BMDCs
when compared to WNV NY99-infected cells respectively
(Figs. 4C & 4D, P,0.01). Thus, a decreased IL-10 production
by WNV H8912-infected splenocytes may contribute to the lower
frequency of virus persistence in spleen compared to that of WNV
NY99-infected mice.
WNV 8912 is also highly attenuated in neurovirulence.
WNV persistence was found at a low frequency in the
brain following an i.c. infection
To determine the neurovirulence of WNV H8912, we infected
mice i.c. with 102, 104 and 106 PFU of WNV H8912. Infected
mice were monitored twice daily for morbidity and mortality for
over a month. All mice inoculated with 104 and 106 PFU of WNV
H8912 infection died; while 41% of mice inoculated i.c. with
102 PFU of WNV H8912 survived (Fig. 5A). To further study its
neurovirulence, we infected mouse primary cortical neuron/glia
cultures with WNV H8912 and its wild-type control WNV NY99.
At days 1 and 3 post-infection, the viral load in WNV H8912-
infected cells was about 75%–80% lower than that in WNV
NY99-infected cells as measured by Q-PCR analysis (Fig. 5B,
P,0.01). Plaque assay results also showed a 94% decrease in viral
titers of WNV H8912- infected cells compared to that of WNV
NY99-infected (Fig. 5C, P,0.05) on day 1 post-infection. We
next studied WNV persistence in the brains of mice that survived
the 102 PFU of WNV H8912 i. c. infection. At day 45 post-
infection, WNV RNA was only detected by Q-PCR assay in one of
the five surviving mice (20%, data not shown). Among the
surviving mice, 60% had a detectable serum WNV-specific IgM
response; whereas 80% of them were positive for WNV-specific
IgG (Figs. 6A and 6B). To determine if WNV persistence in the
brain was accompanied by inflammatory responses, we studied
brain pathology. On day 45 post-infection, we did not detect
significant histologic evidence of inflammation or neuronal
damage in the cortex and olfactory bulb regions of the brain of
surviving mice, when compared to equivalent tissues in non-
infected controls (Figs. S2A & S2B). In further phenotype
analyses of the brain leukocytes by Q-PCR assay, no significant
infiltration of either CD4+ T cells (Fig. 6C), monocytes (CD11b+,
Fig. 6E), or neutrophils (Ly6G+, Fig. 6F) was observed in the
brains of the surviving mice. Nevertheless, we noted one of the
surviving mice- which was also positive for viral RNA, had more
CD8+ T cell infiltrates in the brain (Fig. 6D) at day 45 post-
infection than non-infected controls. Collectively, these results
suggest that WNV H8912 is highly reduced in neurovirulence. It
appears to induce WNV persistence much less frequently in the
brain than in the kidneys with no histopathologic changes in the
CNS.
Discussion
WNV H8912, a viral isolate recovered from urine of persistently
infected hamster, was attenuated in neuroinvasiveness but capable
of producing chronic renal infection in hamsters [27]. In this
study, we found that WNV H8912 was also highly attenuated in
neuroinvasiveness and neurovirulence for mice. Following a
Figure 2. Innate cytokine and antibody production in WNV H8912- infected mice. A–F. Cytokine levels in blood at the indicated time
points post-infection were determined by using Q-PCR or Bioplex. G–H. Sera were collected from non-infected (NF) mice or those infected with WNV
H8912 at day 1 (D1), day 3 (D3), day 6 (D6) and day 10 (D10) post-infection. The development of WNV-specific IgM (G) or IgG (H) antibodies was
determined after incubating sera with absorbed purified r-WNV-E protein. Data are presented as means 6 SEM, n = 4–6. * P,0.05 or **P,0.01
compared to the NF group.
doi:10.1371/journal.pntd.0002275.g002
Table 1. Persistent WNV infection in spleen and kidneys.




Spleen and kidney tissues were harvested from WNV-infected mice at indicated
time points post-infection. Tissue homogenates were passaged serially in Vero
cells for three times. Inoculated cells were harvested and assayed for viral RNA
by Q-PCR analysis. Four to seven of non-infected Vero cell samples were used
each time as negative controls. Samples were considered to be positive for
WNV RNA if the WNVE gene expression level was higher than the negative
controls (P,0.05 or P,0.01 as determined by a non-paired Student’s t test).
doi:10.1371/journal.pntd.0002275.t001
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systemic infection with WNV H8912, viral RNA was detected
more frequently in kidneys than in spleen by a Q-PCR assay. This
was concurrent with a focal chronic inflammation response in the
inter-tubular interstitium of kidney samples found to be positive for
WNV RNA on day 84-post-infection. In comparison, WNV
persisted at a lower frequency in the brain following i.c.
inoculation with no significant changes in the CNS. In summary,
our results suggest that WNV H8912 was highly attenuated and
induced a tissue-specific, persistent renal infection in mice.
B cell-mediated humoral immune responses are critical in host
defense against disseminated infection by WNV [43–45]. Here, we
found that WNV H8912 induced a delayed serum WNV-specific
IgM and a low WNV-specific IgG production in the early stages of
infection, which may contribute to its persistence in the peripheral
tissues. Moreover, the WNV-specific IgM response remained
detectable in the later stages of infection and decreased only
slightly at days 30 and 84 post-infection, compared to that on day
10. WNV-specific IgG production was enhanced at days 30 and
60 post-infection, compared to that in the early stage of infection.
The detection of WNV-specific IgM and IgA in sera of WNV
convalescent patients years after having the acute infection has
been reported and appears to be correlated with the persistence of
viral RNA in the kidneys, urine or the CNS of these patients [14–
16]. Thus, these results further support that WNV H8912 induces
persistent infection in mouse peripheral tissues. T cells are
important for host survival following wild-type WNV infection
and contribute to a long-lasting protective immunity [47–48].
Elevated levels of IL-10 during chronic viral infections are known
to contribute to diminished T cell activity and the failure to control
viral infection [49–50]. Interestingly, sera IL-10 levels in WNV
Figure 3. Kidney pathology and immune responses in WNV H8912 -infected mice. A. Hematoxylin and eosin staining of control non-
infected (NF) mouse and two WNV H8912-infected mice kidney sections at day 84 post-infection; arrows in infected mouse kidney indicate focal
interstitial lymphocytic collection. B–C. Sera were collected from NF and mice that were infected with WNV H8912 at day 10 (D10), day 30 (D30), day
60 (D60) and day 84 (D84) post-infection. The development of WNV-specific IgM (B) or IgG (C) antibodies was determined after incubating sera with
absorbed purified r-WNV-E protein. Data are presented as means 6 SEM, n = 4–12. **P,0.01 compared to NF mice. D–E. Splenocytes and kidney
leukocytes were harvested at indicated time points post-infection and stained for CD8 and WNV- NS4B or WNV -E epitopes. The total numbers of
WNV specific T cells were shown.
doi:10.1371/journal.pntd.0002275.g003
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H8912-infected mice were constitutively high within the first two
weeks of infection. There were also delayed anti-viral responses of
IFNs and IL-1b in these mice. Collectively, these factors may
potentiate persistent viral infection in mouse peripheral tissues
following systemic WNV H8912 infection.
Systemic wild-type WNV NY99 infection induced virus
persistence more frequently in spleen than in mouse kidneys
[19]. In this study, we found WNV H8912 induced virus
persistence preferentially in kidneys following an i.p. infection.
Multiple virus and host determinants could contribute to a tissue –
specific WNV persistence in mice. First, our recent work showed
that WNV H8912 had a significantly reduced replication rate in
mouse kidney epithelial cells compared to wild-type WNV strain
[25], which indicate a greater tissue tropism is not involved in
WNV H8912-induced renal-specific persistence. Differential
immune responses have been reported to contribute to tissue-
specific viral persistence. For example, a Treg-mediated suppres-
sion of CD8+ T cell response occurred specifically in the spleen but
not in the liver during chronic Friend virus infection. This resulted
in a 10-fold less viral load in the latter tissue [51]. Here, we next
measured proinflammatory cytokine responses in spleen and
kidney tissues and found there were lower levels of IL-6 and
TNF-a expression in the kidneys of WNV H8912-infected mice
compared to spleen tissues. This is consistent with our recent
findings, in which WNV H8912 infection in mouse kidney
epithelial cells did not induce IL-6 and TNF-a expression [25].
DC maturation is an innate response that leads to adaptive
immunity to foreign antigens [52–53]. Proinflammatory cytokines
are known to promote this process [54–55]. We found significantly
less WNV-specific CD8+ T cells in WNV persistently infected
kidneys than in the spleen tissues throughout the infection. Thus, a
lower inflammatory response in the kidneys may lead to reduced
WNV specific T cell infiltrates and ultimately to a preferential
WNV persistence in mouse kidneys. Lastly, our results also showed
that splenocytes of WNV H8912-infected mice produced much
less IL-10 than those of wild-type strain-infected mice. There were
higher levels of expression of DC maturation markers on WNV
H8912-infected BMDCs than wild-type WNV –infected cells. In
conclusion, differential proinflammatory cytokine and IL-10
responses in spleen and kidney tissues lead to tissue-specific virus
persistence during systemic WNV infection. WNV H8912 is
highly attenuated in mice. It induced a low frequency of virus
persistence in the CNS following i.c. inoculation, concurrent with
no significant changes in the cortex and olfactory bulb regions of
the brain of surviving mice. Neurons and microglias are the two
major cell types permissive to WNV infection [29,56]. Our results
showed that WNV H8912 had a significantly lower titer in mouse
primary cortical neuron/glia cultures compared to wild-type
WNV strain, which suggests WNV H8912 does not have a tissue
tropism in the CNS. While the underlying mechanisms by which
Figure 4. Splenic T cell responses and DC maturation during WNV NY99 or H8912 infection. A–B. Splenocytes of WNV NY99 or H8912-
infected mice at day 8 and day 35 post-primary infection were cultured ex vivo with WNV peptides for 5 h (A) or with PMA plus ionomycin (B) for 24 h.
A. Cells were harvested and stained for IFN-c, and CD4 or CD8. B. Cell culture supernatant was collected and IL-10 was measured by Bioplex. C–D. DC
maturation in WNV-infected BM-DCs. The percentages of CD80+ (C) and CD86+ (D) on BM-DCs were shown. Data are presented as means 6 SEM, n = 3
or 4. **P,0.01 for WNV NY99 vs. WNV H8912.
doi:10.1371/journal.pntd.0002275.g004
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WNV H8912-induced a low frequency of viral persistence are
under investigation, these results further support that WNV
H8912 induces a tissue-specific renal persistence.
WNV encephalitis (neuroinvasive disease) has been a serious
public health concern in North America for more than a decade.
Neither treatment nor human vaccines are available. In recent
years, some WNV convalescent patients have been reported to
have persistent sequelae, which occurred 6 to 12 months after the
acute infection [9,11]. Murray et al. [18] detected the presence of
WNV RNA in the urine of patients convalescent from WNV
neuroinvasive disease for up to 1–7 years after their initial
infection. Among these WNV RNA-positive patients, 80%
reported chronic neurological symptoms, while 20% had renal
failure [18]. These observations raise the possibility that persistent
infection is associated with WNV-induced chronic diseases.
Persistent WNV infection was detected in the hamster kidneys
and brain, accompanied by neurological sequelae [21–23]; this
association is similar to the clinical findings in some WNV
convalescent patients having long-term morbidity. Compared to
the parent wild-type NY99 strain, full genome sequencing reveals
conserved genetic mutations in the coding and non-coding
regions of the viral genome of all WNV isolates recovered from
urine of persistently infected hamsters [27], including WNV
H8912, indicating an association of genetic mutations with WNV
persistence renal tropism. Thus, hamster model would likely serve
as a suitable in vivo model to further investigate the underlying
immune mechanisms of WNV persistence. Nevertheless, there is
an obstacle to fully investigating immunity to chronic WNV
infection in the hamster model, due to limited availability of
hamster reagents. Mice are easier to work with, amenable to
immunological manipulation and are relatively inexpensive.
Systemic wild-type WNV NY99 infection in mice induced virus
persistence preferentially in spleen tissues than in kidneys [19].
Our study has now shown that the hamster-derived WNV urine
isolate H8912 induced persistent infection in mouse kidneys,
accompanied by focal renal histological inflammatory changes for
up to a few months post infection, which is similar to the
observations in WNV convalescent patients having long-term
morbidity. Thus, defining a murine model of WNV persistence
by using a well-characterized, hamster-derived WNV urine
isolate should provide important insights into the mechanisms
of WNV CNS persistence and its associated neurological
sequelae. This information may enable us to define the elements
of the immune response that fail or are insufficient to mediate
WNV clearance in the infected animals and ultimately help us to
set therapeutic goals to modulate immune functions pharmaco-
logically and create vaccines which could induce robust T cell
memory responses.
Figure 5. WNV H8912 exhibited a significantly reduced neurovirulence. A. Mice were injected i.c. with different doses of WNV H8912 and
monitored twice daily. B–C. Mouse primary cortical neuron/glia cultures were infected with WNV H8912 and its wild-type controls WNV NY99. Viral
load at indicated time points post-infection was determined by Q-PCR assay (B) or by plaque assay (C). Data are presented as means 6 SEM, n = 3. *
P,0.05 or **P,0.01 compared to WNV NY99-infected cells.
doi:10.1371/journal.pntd.0002275.g005
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Supporting Information
Figure S1 Cytokine levels in spleen and kidney tissues
in WNV H8912- infected mice. IL-6 (A), TNF-b (B), TGF-b
(C) and IL-10 (D) gene expression in the spleen and kidney
tissues at the indicated time points post infection were
determined by using Q-PCR. The fold of increase compared
to that of the mock group is shown. Data are presented as means
6 SEM, n = 3–6.
(TIF)
Figure S2 Brain pathology at day 45 post-WNV H8912
infection. Hematoxylin and eosin staining of the cortex (A) and
olfactory bulb (B) regions of control non-infected (NF) and WNV
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Figure 6. Antibody production and brain leukocyte infiltration at day 45 post- infection. A–B. Sera were collected from non-infected (NF)
or mice which were intracranially (i. c.) infected with WNV H8912 at day 45 (D45) post-infection. The development of WNV-specific IgM (A) or IgG (B)
antibodies was determined. C–F. Levels of CD4+ T cell (C), CD8+ T cell (D), monocyte (CD11b, E) and neutrophil (Ly6G, F) expression in the three WNV-
infected mice brains were measured by Q-PCR assay at day 45 post-infection. The y-axis depicts the ratio of the amplified CD4, CD8, CD11b or Ly6G
cDNA to b-actin cDNA of each sample. The dotted line represents the mean of NF samples.
doi:10.1371/journal.pntd.0002275.g006
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